PBYI — Puma Biotechnology Share News
0.000.00%
Last trade - 00:00- $581.24m
- $487.34m
- $228.37m
Brief: Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(C)(4)
Puma Biotechnology Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Puma Biotechnology Q2 Adjusted EPS USD 0.15
Puma Biotechnology Inc expected to post earnings of 10 cents a share - Earnings Preview
Brief: Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Puma Biotechnology Inc reports results for the quarter ended March 31 - Earnings Summary
Brief: Puma Biotechnology Q1 Adjusted EPS USD 0.1
Puma Biotechnology Inc expected to post a loss of 2 cents a share - Earnings Preview
Puma Biotechnology Inc reports results for the quarter ended December 31 - Earnings Summary
Brief: Puma Biotechnology Q4 Adjusted EPS USD 0.43
Puma Biotechnology Inc expected to post earnings of 10 cents a share - Earnings Preview
Brief: Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(C)(4)
Brief: Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(C)(4)
Brief: Puma Biotechnology Announces Initiation of ALISCA-Breast1 Phase II Trial of Alisertib in Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer
Puma Biotechnology Inc reports results for the quarter ended September 30 - Earnings Summary
Brief: Puma Biotechnology Q3 Adjusted EPS USD 0.46
AstraZeneca gets $107 mln Pfizer verdict overturned in US cancer drug patent fight
Puma Biotechnology Inc reports results for the quarter ended in June - Earnings Summary
Brief: Puma Biotechnology Q2 Adjusted EPS USD -0.05